Download PDF
CC BY-NC-ND 4.0 · World J Nucl Med 2018; 17(03): 207-210
DOI: 10.4103/wjnm.WJNM_51_17
Case report

Fluorodeoxyglucose, sodium fluoride, and prostate-specific membrane antigen positron emission tomography studies for treatment response assessment in prostate cancer

Ismet Sarikaya
Department of Nuclear Medicine, Faculty of Medicine, Kuwait University
,
Abdelhamid Elgazzar
Department of Nuclear Medicine, Faculty of Medicine, Kuwait University
,
Ali Sarikaya
1   Department of Nuclear Medicine, Faculty of Medicine, Trakya University, Edirne, Turkey
,
Mahmoud Alfeeli
2   Department of Nuclear Medicine, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints

Various positron emission tomography (PET) studies are available for prostate cancer which show various successes at demonstrating primary, recurrent, or metastatic tumor and assessing response to treatment. In this case report, we will present and compare pre- and post-therapy fluorodeoxyglucose, sodium fluoride, and gallium-68 prostate-specific membrane antigen PET images of a patient with prostate cancer.

Keywords

Fluorodeoxyglucose - gallium-68 prostate-specific membrane antigen - prostate cancer - sodium fluoride - treatment response assessment


Publication History

Article published online:
17 May 2022

© 2018. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India